TP53 and myelodysplastic syndrome: In another study of the effect of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes, only TP53 mutations with VAF  40% were an independent factor for inferior survival in multivariate analysis [22].